Witnesses testified before the committee about the use of anti-depressant drugs in treating children. They discussed the danger of over-prescription, the risk that some anti-depressants may increase the incidence of suicidal thoughts in children, and Food and Drug Administration procedures. The witnesses responded to questions from committee members.